Corporate Profile

SBI Biotech Co., Ltd. is a bio-venture firm envisaged and founded by SBI Holdings President & CEO, Mr. Yoshitaka Kitao and Molecular Biologist, Dr. Ken-ichi Arai.

Corporate Fact Sheet

As of September 1, 2023

Corporate Name	SBI Biotech Co., Ltd.
Capital	100,000 thousand Yen
Board of Directors	Representative Director, President Takeshi Irie Director Eiji Esashi,PhD Director Shunya Ugachi Director Masahiro Kami,PhD Director Atsushi Miyajima,PhD
Board of Corporate Auditors	Standing Corporate Auditor Ichiro Hamamoto Corporate Auditor Junji Maruko Corporate Auditor Hisayori Kataoka
Date of Foundation	March 30,2001
Head Office	Izumi Garden Tower 9F 1-6-1 Roppongi, Minato-ku Tokyo 106-6009Map Telephone:+81-3-6229-0787 Fax:+81-3-3583-2022
Number of shares issued	102,672
Employee	22

Origin of Corporate Name

We named our company "SBI Biotech" to indicate our wishes, as the first bio-venture firm in the SBI Group, to contribute to society through commercializing various promising and innovative drug seeds.